Silo Pharma (SILO) News Today $0.89 -0.05 (-5.33%) (As of 05:46 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Expands By 59.8%December 30 at 6:47 AM | americanbankingnews.comSilo Pharma (NASDAQ:SILO) Shareholders Approve Key Proposals at Annual MeetingDecember 22, 2024 | americanbankingnews.comSilo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and FibromyalgiaDecember 18, 2024 | globenewswire.comSilo Pharma partners with Kymanox to develop ketamine implantDecember 3, 2024 | msn.comSILO Pharma (NASDAQ:SILO) Stock, Insider Trading ActivityDecember 1, 2024 | benzinga.comSilo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain ManagementNovember 29, 2024 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related DisordersNovember 18, 2024 | finanznachrichten.deSilo Pharma Study Of SPC-15 Shows Potential For Depressive, Stress-Related DisordersNovember 18, 2024 | markets.businessinsider.comSilo Pharma discloses ‘promising results’ from preclinical study on SPC-15November 18, 2024 | markets.businessinsider.comSilo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related DisordersNovember 18, 2024 | globenewswire.comSilo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023)November 16, 2024 | sg.finance.yahoo.comWhy 77,000 Cancer Patients Are Suing Pfizer (& Others)November 5, 2024 | msn.comSilo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine ImplantOctober 31, 2024 | globenewswire.comSilo Pharma, Inc. (SILO)October 26, 2024 | finance.yahoo.comSilo Pharma, Inc.: Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSDSeptember 10, 2024 | finanznachrichten.deSilo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSDSeptember 10, 2024 | globenewswire.comInvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant TherapeuticAugust 15, 2024 | msn.comHealth Care Up After Cardinal Earnings -- Health Care RoundupAugust 15, 2024 | marketwatch.comSilo Pharma Shares Jump 11% on Ketamine-Treatment PartnershipAugust 15, 2024 | marketwatch.comSilo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant TherapeuticAugust 14, 2024 | globenewswire.comSilo Pharma Announces Partnership with Global CRO for Central Nervous System Homing PeptideAugust 7, 2024 | globenewswire.comSilo Pharma to Present at H.C. Wainwright Annual Global Investment ConferenceJuly 26, 2024 | globenewswire.comSilo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 22, 2024 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 19, 2024 | finanznachrichten.de3 Penny Stocks to Watch Now, 7/18/24July 19, 2024 | msn.comSilo Pharma Finds Partner For Device Development for Intranasal PTSD DrugJuly 19, 2024 | msn.comSilo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 19, 2024 | globenewswire.comWhy Is Silo Pharma (SILO) Stock Up 60% Today?July 18, 2024 | investorplace.comSilo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15July 18, 2024 | globenewswire.comWhy Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?July 16, 2024 | benzinga.comWhy Is Silo Pharma (SILO) Stock Up 123% Today?July 16, 2024 | investorplace.comSilo Pharma Secures Exclusive Global License for Alzheimer's TherapeuticJuly 16, 2024 | globenewswire.comSilo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and AnxietyJune 26, 2024 | globenewswire.comSilo Pharma Announces Successful Production of its SP-26 Ketamine Implant for FibromyalgiaJune 7, 2024 | globenewswire.comSilo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 6, 2024 | globenewswire.comSilo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and AnxietyJune 4, 2024 | globenewswire.comJaguar Health, Altamira Therapeutics,Erasca among healthcare moversMay 23, 2024 | msn.comSilo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse PreventionMay 21, 2024 | globenewswire.comSilo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in KetamineMay 14, 2024 | globenewswire.comMultiple sclerosis patients find hope in ‘liquid gold’May 1, 2024 | msn.com‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit’April 30, 2024 | msn.comSilo Pharma reports promising SPC-15 study for PTSD therapyApril 25, 2024 | investing.comSilo Pharma, Inc. (SILO) Stock Price, News, Quote & History - Yahoo FinanceApril 25, 2024 | finance.yahoo.comSilo Pharma Announces Positive Results for Intranasal PTSD TreatmentApril 23, 2024 | finance.yahoo.comSilo Pharma Announces Positive Results for Intranasal PTSD TreatmentApril 23, 2024 | globenewswire.comPsyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & MoreApril 17, 2024 | msn.comSilo Pharma, Inc.: Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer's Disease TherapeuticApril 10, 2024 | finanznachrichten.deSilo Pharma Exercises Option To License AD Therapeutic SPC-14 From Columbia UniversityApril 10, 2024 | markets.businessinsider.comSilo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease TherapeuticApril 10, 2024 | finance.yahoo.comSilo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer's Disease TherapeuticApril 10, 2024 | globenewswire.com Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address Kamala’s final humiliation (Ad)The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware of… yet have the potential to deliver colossal returns over the next four years. I’m not talking about Tesla, Palantir, or anything else you’ve heard parroted by the mainstream financial press. No. These are Trump’s Secret Stocks. It’s all waiting for you here. SILO Media Mentions By Week SILO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SILO News Sentiment▼-0.020.59▲Average Medical News Sentiment SILO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SILO Articles This Week▼21▲SILO Articles Average Week Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MGO Global News Today Lululemon Athletica News Today Amer Sports News Today Birkenstock News Today Gildan Activewear News Today Levi Strauss & Co. News Today The Baldwin Insurance Group News Today Under Armour News Today Ermenegildo Zegna News Today Under Armour News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SILO) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
